Skip to main content
. 2021 Feb 24;12(2):103–114. doi: 10.5306/wjco.v12.i2.103

Table 2.

Patient characteristics


irAE

Overall
Yes
No
P value
n
mean
SD
n
mean
SD
n
mean
SD

Age at ICPi initiation 293 63.3 12.8 91 66.1 13.2 202 62.0 12.4 0.0108

irAE: Immune-related adverse events; ICPi: Immune checkpoint inhibitors.